Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Electronic Hard Copy An Evaluation of Products and Technologies for Molecular Diagnostics within Oncology HBS Consulting, May 2006   Description     Table of Contents     Methodology        Enquire before Buying    Send to a Friend   This latest Multi Client Publication provides: - An overview of current industry-landscape for molecular diagnostics within the oncology area - Analysis of the key European markets including forecasts for growth, drivers and restraints in the marketplace - Reimbursement and legislation environment, the most relevant national guidelines relating to genetic testing - Understanding of market opportunities for molecular diagnostics within the oncology market as an area of growth, research and future developments - Data in Excel Spreadsheet The primary objective of this report, compiled from an analysis of primary and secondary research data, is to provide an overview of the molecular diagnostics market for selected oncology markers in the country markets listed below. - France - Germany - Italy - United Kingdom - USA The following key issues have been addressed: - Provide a reflective picture of the type and number of relevant testing institutions - Which and how many parameters are tested (market size). Top 3 solid markers, top 3 lymphoid markers and emerging markers identified. - Which assays are used (home brew or commercial) - Current market growth per parameter - Expected market growth rates per parameter in the next 5 years - Which technologies are used (PCR, RT-PCR, FISH, sequencing, microarrays, others) and what is the anticipated shift in use of these. - Devices used - The regulatory issues per country (legislation, reimbursement etc.) - Future trends & emerging technologies Product samples Overview of Molecular Diagnostics within Oncology Customers who bought this item also bought Biomarker Technology Platforms for Cancer Diagnoses and Therapies Molecular Diagnostics Markets Cancer Diagnostic Testing World Markets Molecular Diagnostics: Transforming Pharmaceuticals, Impacting New Markets European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications Molecular Diagnostics - Technologies, Markets and Companies Cardiac Marker Diagnostic Testing Markets The Cancer Diagnostics Market: Emerging Opportunities And Business Expansion Strategies Nucleic Acid Testing Markets in Malaysia (2005-2010) Nucleic Acid Testing Markets in Taiwan Nucleic Acid Testing Markets in China How Overcoming the Challenge of Biomarker Validation Can Pay Off for Drug and Diagnostic Developers

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster